Advertisement
The leading life science news channel in the Nordic region.
Prio - November 6, 2022
The three Nobel Laureates in Chemistry 2022 have brought chemistry into the era of functionalism and created a new genre in chemical biology. The Royal Swedish Academy of Sciences decided to award the 2022 Nobel Prize in Chemistry to Carolyn R. Bertozzi, Morten Meldal and K. Barry Sharpless, for the development of click chemistry and […]
Uncategorized - November 3, 2022
A Finnish-led international research team has discovered novel gene variants that increase the risk of a rare but severe lung disease, idiopathic pulmonary fibrosis. The results also demonstrate notable genetic similarities with susceptibility to severe COVID-19 infection, reports HiLIFE. The study, led by the University of Helsinki, identified seven previously novel genetic risk factors. Only […]
Iceland - November 2, 2022
Scientists at deCODE genetics in Iceland have discovered rare, protective loss-of-function variants that point to potential drug targets for nonalcoholic fatty liver disease (NAFLD). Last week, the scientists published a large genome-wide association study on nonalcoholic fatty liver disease (NAFLD) in Nature Genetics. Sequence variants that associate with NAFLD were identified, including rare, protective loss-of-function […]
Profiles in Science - November 1, 2022
Who we are as a species is something that is both a philosophical and scientific question. The history of modern humans has continuously been shown to be much more complex than previously imagined, and thanks to the work of Svante Pääbo, we have answers to questions that may have remained unanswered.
Profiles in Science - November 1, 2022
The philosophical aspect of chemistry led Morten Meldal to the field and he loves, and cannot help thinking about, the next solution and the intriguing questions about our being and about the universe.
Clinical Trials - November 1, 2022
Gesynta Pharma has announced the decision to advance the development of its clinical-stage drug candidate GS-248 in endometriosis. This strategically important decision follows a recent preclinical proof-of-concept study with GS-248 in an advanced model of endometriosis, where disease-modifying properties of the drug candidate were firmly established, states the company in a press release. These data […]
In a new job - November 1, 2022
XNK Therapeutics has announced the appointment of Anna-Karin Maltais as Chief Scientific Officer. She will be a member of the company’s management team. “At XNK, Anna-Karin’s experience in research and development will be invaluable as the company continues to grow into new indications,” says Johan Liwing, CEO of XNK Therapeutics. “We are very happy to […]
Acquisition - October 31, 2022
Through the acquisition of Norwegian company Diatec, Curida takes the first steps into biological production. The acquisition strengthens the base on which Curida aims to grow further in the international CDMO market, it states. Before the acquisition, Curida provides manufacturing and development services out of two sites in Norway, and exports to more than 80 […]
Column - October 31, 2022
Staffan Svärd, Professor, Scientific Lead for SciLifeLab’s Pandemic Laboratory Preparedness Capability, writes about how lessons learned from the COVID-19 pandemic can increase our pandemic preparedness. Early in the pandemic, SciLifeLab, together with Knut and Alice Wallenberg Foundation, launched a major national COVID-19 research program. Today SciLifeLab has a government mandate to coordinate and expand the […]
Global report - October 29, 2022
This weekend most countries in Europe will spring backward one hour. We take a closer look upon how our inner clock regulates critical functions like behavior, hormone levels, sleep, body temperature and metabolism. Daylight Saving Time (DST) is not removed in 2022 despite the fact that the European Parliament voted to end daylight saving time in […]
This site uses cookies